Loading clinical trials...
Loading clinical trials...
A Phase 2 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions
Interventions
Orca-T
Locations
5
United States
UCLA Department of Medicine
Los Angeles, California, United States
Moffitt Cancer Center
Tampa, Florida, United States
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
Oregon Health and Science University
Portland, Oregon, United States
Vanderbilt University, Ingram Cancer Center
Nashville, Tennessee, United States
Start Date
December 9, 2025
Primary Completion Date
November 1, 2027
Completion Date
December 1, 2028
Last Updated
April 15, 2026
NCT06303193
NCT06847867
NCT06656494
NCT05588154
NCT04726241
NCT06465953
Lead Sponsor
Orca Biosystems, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions